Live Breaking News & Updates on Poseida Therapeutics Inc
Stay updated with breaking news from Poseida therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […] ....
Poseida Therapeutics, Inc. (NASDAQ:PSTX – Free Report) – Investment analysts at HC Wainwright upped their Q2 2024 EPS estimates for Poseida Therapeutics in a research report issued to clients and investors on Wednesday, May 22nd. HC Wainwright analyst A. He now anticipates that the company will earn ($0.43) per share for the quarter, up from […] ....
HC Wainwright reaffirmed their buy rating on shares of Poseida Therapeutics (NASDAQ:PSTX – Free Report) in a research note published on Wednesday, Benzinga reports. HC Wainwright currently has a $20.00 target price on the stock. HC Wainwright also issued estimates for Poseida Therapeutics’ Q2 2024 earnings at ($0.43) EPS, Q3 2024 earnings at ($0.46) EPS, […] ....
Poseida Therapeutics (NASDAQ:PSTX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They presently have a $20.00 price target on the stock. Poseida Therapeutics Price Performance Poseida Therapeutics stock opened at $2.97 on Wednesday. Poseida Therapeutics has a one […] ....